We serve Chemical Name:NS309 CAS:18711-16-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:NS309
CAS.NO:18711-16-5
Synonyms:1H-Indole-2,3-dione, 6,7-dichloro-, 3-oxime, (3E)-;6,7-Dichloro-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-one;NS-309;6,7-dichloro-1H-indole-2,3-dione-3-oxime;(3E)-6,7-Dichloro-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-one;6,7-dichloroisatin 3-oxime;1H-Indole-2,3-dione, 6,7-dichloro-, 3-oxime;6,7-Dichloro-1H-indole-2,3-dione 3-oxime;3-Oxime-6,7-dichloro-1H-indole-2,3-dione;NS309
Molecular Formula:C8H4Cl2N2O2
Molecular Weight:231.036
HS Code:2933790090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.8±0.1 g/cm3
Index of Refraction:1.742
PSA:61.69000
Exact Mass:229.964981
LogP:2.66
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 1H-Indole-2,3-dione, 6,7-dichloro-, 3-oxime, (3E)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,NS309 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,NS-309 Use and application,6,7-Dichloro-1H-indole-2,3-dione 3-oxime technical grade,usp/ep/jp grade.
Related News: Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. NS309 manufacturer Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. NS309 supplier Health officials said it remained unclear where he had developed the disease. NS309 vendor Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. NS309 factory Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant.